Silence Therapeutics plc Unaudited Preliminary Results for the Year Ended 31 December 2009
LONDON, April 29 /PRNewswire/ — Silence Therapeutics plc (AIM: SLN) (“Silence” or the “Company”) announces its results for the year ended 31 December 2009. On 5 January 2010, Silence merged with U.S.-based RNA interference (RNAi) therapeutic company, Intradigm Corporation, to form a leading company in the field of RNAi.
Beer Pong N-Ice Rack Product Review